BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Medtronic
Boehringer Ingelheim
Federal Trade Commission
Cipla
QuintilesIMS
Express Scripts
Accenture
Teva
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

CETIRIZINE HYDROCHLORIDE HIVES Drug Profile

« Back to Dashboard

When do Cetirizine Hydrochloride Hives patents expire, and what generic alternatives are available?

Cetirizine Hydrochloride Hives is a drug marketed by Dr Reddys Labs Ltd, Ipca Labs Ltd, Jubilant Cadista, Mylan, Orchid Hlthcare, Perrigo R And D, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Unichem, Unique Pharm Labs, Bionpharma Inc, Amneal Pharms Ny, Aurobindo Pharma Ltd, Taro, and Torrent Pharms Llc. and is included in sixteen NDAs.

The generic ingredient in CETIRIZINE HYDROCHLORIDE HIVES is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-seven suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Drug patent expirations by year for CETIRIZINE HYDROCHLORIDE HIVES
Pharmacology for CETIRIZINE HYDROCHLORIDE HIVES
Medical Subject Heading (MeSH) Categories for CETIRIZINE HYDROCHLORIDE HIVES

US Patents and Regulatory Information for CETIRIZINE HYDROCHLORIDE HIVES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Llc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 079191-002 Apr 15, 2010 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 090760-004 Aug 5, 2015 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 078072-002 Jul 22, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078343-001 Jan 15, 2008 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078680-002 Jun 26, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 077631-002 Jan 11, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 076677-004 Dec 27, 2007 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ipca Labs Ltd CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 202277-003 Mar 11, 2014 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo R And D CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078336-004 Dec 27, 2007 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unique Pharm Labs CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 077829-002 Aug 26, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Deloitte
Farmers Insurance
Mallinckrodt
Fish and Richardson
Medtronic
Chubb
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot